February 23, 2021 — Hologic, Inc. has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million.
February 23, 2021 — A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
February 23, 2021 — icometrix, world leader in imaging artificial intelligence (AI) solutions for people with neurological conditions, announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio.
February 22, 2021 — Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy.
February 22, 2021 — According to an open-access article in ARRS' American Journal of Roentgenology (AJR), COVID-19-related disseminated leukoencephalopathy (CRDL) represents an important--albeit uncommon--differential consideration in patients with neurologic manifestations of coronavirus disease (COVID
February 22, 2021 — Modern medical technology is helping scholars tell a more nuanced story about the fate of an ancient king whose violent death indirectly led to the reunification of Egypt in the 16th century BC. The research was published in Frontiers in Medicine.
